Company Registration No. 07054924 (England and Wales)
SNR PHARMA LTD
Unaudited accounts
for the year ended 31 July 2025
SNR PHARMA LTD
Unaudited accounts
Contents
SNR PHARMA LTD
Company Information
for the year ended 31 July 2025
Director
Rifat Nasreen Asghar Hussain
Company Number
07054924 (England and Wales)
Registered Office
319 SAREHOLE ROAD
HALL GREEN
BIRMINGHAM
WEST MIDLANDS
B28 0AL
Accountants
Caldwell House Consulting
44 Caldwell Road
Birmingham
West Midlands
B9 5TQ
SNR PHARMA LTD
Statement of financial position
as at 31 July 2025
Intangible assets
230,000
230,000
Total assets less current liabilities
230,000
230,000
Creditors: amounts falling due after more than one year
(401,498)
(401,498)
Net liabilities
(171,498)
(171,498)
Called up share capital
1,000
1,000
Profit and loss account
(172,498)
(172,498)
Shareholders' funds
(171,498)
(171,498)
For the year ending 31 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 29 July 2026 and were signed on its behalf by
Rifat Nasreen Asghar Hussain
Director
Company Registration No. 07054924
SNR PHARMA LTD
Notes to the Accounts
for the year ended 31 July 2025
SNR PHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 07054924. The registered office is 319 SAREHOLE ROAD, HALL GREEN, BIRMINGHAM, WEST MIDLANDS, B28 0AL.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover represents income received for provision of management services.
Intangible fixed assets (including purchased goodwill) are amortised.
4
Intangible fixed assets
Goodwill
5
Creditors: amounts falling due after more than one year
2025
2024
Amounts owed to group undertakings and other participating interests
36,204
36,204
Other creditors
365,294
365,294
SNR PHARMA LTD
Notes to the Accounts
for the year ended 31 July 2025
Allotted, called up and fully paid:
1,000 Ordinary shares of £1 each
1,000
1,000
7
Average number of employees
During the year the average number of employees was 0 (2024: 0).